RAIMONDO, Giovanni
 Distribuzione geografica
Continente #
EU - Europa 12.989
NA - Nord America 11.392
AS - Asia 6.288
SA - Sud America 2.145
AF - Africa 205
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 5
Totale 33.041
Nazione #
US - Stati Uniti d'America 11.166
RU - Federazione Russa 6.595
SG - Singapore 2.501
CN - Cina 1.948
BR - Brasile 1.859
IE - Irlanda 1.600
SE - Svezia 1.418
IT - Italia 857
HK - Hong Kong 682
DE - Germania 581
UA - Ucraina 406
FR - Francia 373
VN - Vietnam 359
FI - Finlandia 302
PL - Polonia 268
GB - Regno Unito 250
IN - India 180
CA - Canada 107
AR - Argentina 93
BD - Bangladesh 89
BE - Belgio 76
MX - Messico 67
TR - Turchia 67
AT - Austria 59
ZA - Sudafrica 59
ID - Indonesia 57
IQ - Iraq 56
EC - Ecuador 45
NL - Olanda 44
JP - Giappone 43
PK - Pakistan 41
CO - Colombia 39
ES - Italia 39
MA - Marocco 38
UZ - Uzbekistan 37
CZ - Repubblica Ceca 31
VE - Venezuela 27
CI - Costa d'Avorio 24
PY - Paraguay 23
AE - Emirati Arabi Uniti 19
CL - Cile 19
KE - Kenya 18
AZ - Azerbaigian 17
JO - Giordania 17
LT - Lituania 17
PH - Filippine 17
SA - Arabia Saudita 16
BO - Bolivia 15
TN - Tunisia 15
DZ - Algeria 14
IL - Israele 14
LB - Libano 14
NP - Nepal 14
IR - Iran 13
KZ - Kazakistan 13
PE - Perù 13
JM - Giamaica 12
KG - Kirghizistan 12
MY - Malesia 12
NZ - Nuova Zelanda 11
UY - Uruguay 11
GR - Grecia 10
OM - Oman 9
EG - Egitto 8
EE - Estonia 7
HN - Honduras 7
PT - Portogallo 7
AU - Australia 6
BG - Bulgaria 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
LV - Lettonia 6
BY - Bielorussia 5
BZ - Belize 5
GT - Guatemala 5
KW - Kuwait 5
NO - Norvegia 5
PS - Palestinian Territory 5
SN - Senegal 5
AM - Armenia 4
AO - Angola 4
CR - Costa Rica 4
KR - Corea 4
PA - Panama 4
RO - Romania 4
RS - Serbia 4
SY - Repubblica araba siriana 4
AL - Albania 3
BN - Brunei Darussalam 3
DK - Danimarca 3
EU - Europa 3
LY - Libia 3
MD - Moldavia 3
QA - Qatar 3
SV - El Salvador 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
GE - Georgia 2
HU - Ungheria 2
Totale 33.009
Città #
Ashburn 2.253
Moscow 2.022
Dublin 1.599
Singapore 1.450
Dallas 1.335
Chandler 1.074
Nyköping 837
Jacksonville 836
Beijing 682
Hong Kong 679
San Jose 574
Messina 414
The Dalles 338
Los Angeles 263
Ann Arbor 253
Warsaw 249
Princeton 246
Medford 223
Lauterbourg 216
Cambridge 188
Des Moines 179
Munich 167
São Paulo 157
Dearborn 145
New York 131
Ho Chi Minh City 128
Boardman 118
Buffalo 92
Woodbridge 85
Wilmington 81
Houston 79
Council Bluffs 77
Jinan 74
Tianjin 73
Brussels 72
Frankfurt am Main 69
Hanoi 68
Redondo Beach 66
Orem 64
Helsinki 62
Guangzhou 59
San Mateo 58
Rio de Janeiro 57
Nanjing 54
Santa Clara 54
Shenyang 54
Belo Horizonte 53
Brasília 53
Turku 50
Rome 45
Seattle 43
Chennai 42
Tokyo 42
Nuremberg 40
Hebei 38
Vienna 37
Brooklyn 36
Falls Church 36
Pune 36
Haikou 35
Shanghai 32
Shenzhen 32
Zhengzhou 32
Chicago 31
Tashkent 31
Jakarta 30
Stockholm 30
Catania 29
Phoenix 29
Montreal 28
Atlanta 27
Hyderabad 27
Porto Alegre 27
Baghdad 26
Curitiba 26
Amsterdam 25
Bremen 25
San Francisco 25
Abidjan 24
Boston 24
Johannesburg 24
Lancaster 23
Brno 22
Denver 22
Dong Ket 22
Guarulhos 21
London 21
Ottawa 21
Campinas 20
Hangzhou 20
Mexico City 20
Nanchang 20
Ningbo 20
Manchester 19
Mumbai 19
Poplar 19
Düsseldorf 18
Haiphong 18
Milan 18
Ankara 16
Totale 19.603
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 382
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 273
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 268
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 268
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 264
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 256
Atrial fibrillation in patients with cirrhosis 249
Hepatitis B virus (HBV) markers and HBV-DNA in serum and liver tissue of patients with acute exacerbation of chronic type B hepatitis 228
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 228
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 221
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 216
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 215
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 212
HBE ANTIBODY UNRELATED TO E-MINUS HEPATITIS-B VIRUS VARIANT INFECTION IN PATIENTS WITH CHRONIC TYPE-D HEPATITIS 210
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 210
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 210
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 209
Does the margin width influence recurrence rate in liver surgery for hepatocellular carcinoma smaller than 5 cm? 208
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 207
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? 205
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 202
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 202
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta virus superinfection. 200
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 200
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 198
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 198
Erectile dysfunction in compensated liver cirrhosis 198
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers 194
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 194
Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease. 193
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 193
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 192
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 190
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 189
Control of cccDNA function in hepatitis B virus infection. 189
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 187
Exacerbation of chronic liver disease due to hepatitis B surface antigen after delta infection. 186
ALFA-INTERFERON TREATMENT INDUCES INSULIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS 184
Cirrhosis related to wild-type HBV infection in siblings with A3 - B35 - Cw4 HLA class I phenotype. 184
HEPATITIS-B VIRUS VARIANT, WITH A DELETION IN THE PRES2 AND 2 TRANSLATIONAL STOP CODONS IN THE PRECORE REGIONS, IN A PATIENT WITH HEPATOCELLULAR-CARCINOMA 183
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 183
[A glance into the past ... Southern and northern blot: really superseded?] 181
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 181
Mitochondrial DNA is a target of HBV integration 180
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 179
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 176
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 176
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 175
A 2010 update on occult hepatitis B infection. 174
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 170
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 170
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 170
Clinical virology of hepatitis B virus infection 168
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 168
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 168
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 167
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. 167
A NEW HEPATITIS-B VIRUS VARIANT IN A CHRONIC CARRIER WITH MULTIPLE EPISODES OF VIRAL REACTIVATION AND ACUTE HEPATITIS 165
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 164
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 162
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 162
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 162
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 162
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 161
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 161
Low prevalence of hepatitis B and hepatitis C virus serum markers in a cohort of pregnant women from Southern Italy 160
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 159
Correlates of total homocysteine plasma concentration in type 2 diabetes 157
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 157
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta superinfection. 156
Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. 155
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 155
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 155
Disease progression and liver cancer in the ferroportin disease. 155
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 155
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 154
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 (IL8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY 152
Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B 152
Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma 151
BILE DUCTOPENIA FOLLOWING THERAPY WITH SULPIRIDE 151
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 151
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 150
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 149
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 149
HISTOLOGICAL BEHAVIOR OF CHRONIC HEPATITIS IN PATIENTS TREATED WITH ALPHA-INTERFERON 148
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 148
Monofocal hepatocellular carcinoma: How much does size matter? 147
Obesity and liver cancer 147
ABNORMAL ALANINE AMINOTRANSFERASE ACTIVITY REFLECTS EXPOSURE TO HEPATITIS-C VIRUS IN HEMODIALYSIS-PATIENTS 146
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 146
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 146
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 145
Seroprevalence of hepatitis B virus and hepatitis C virus infections in elderly residents in nursing homes in Southern Italy 145
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. 144
NS3 genetic variability in hepatitis C virus genotype-1b isolates from liver specimens and blood samples of treatment naïve patients with chronic hepatitis C 144
Pattern of macrovascular invasion in hepatocellular carcinoma 143
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study 143
The changing scenario of hepatocellular carcinoma in Italy: an update 142
CHRONIC HEPATITIS IN PATIENTS WITH ACTIVE HEPATITIS-B VIRUS AND HEPATITIS-C VIRUS COMBINED INFECTIONS - A HISTOLOGICAL STUDY 141
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 N(IL-8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INERFERON ALFA ANTIVIRAL ACITIVITY 141
Totale 18.086
Categoria #
all - tutte 109.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.627


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202174 0 0 0 0 0 0 0 0 0 0 0 74
2021/20221.639 20 153 48 58 95 33 126 59 29 281 216 521
2022/20234.528 334 464 224 320 309 451 81 246 1.896 31 134 38
2023/20241.189 81 180 54 104 100 197 19 248 6 56 34 110
2024/20255.245 78 75 139 347 274 221 209 1.054 1.232 309 460 847
2025/202616.320 718 1.237 1.211 1.097 1.285 3.393 2.031 1.964 2.047 731 302 304
Totale 33.494